You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 43 No. 7, July 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Longitudinal Measurement of Plasma Homovanillic Acid Levels in Schizophrenic Patients

Correlation With Psychosis and Response to Neuroleptic Treatment

David Pickar, MD; Rodrigo Labarca, MD; Allen R. Doran, MD; Owen M. Wolkowitz, MD; Alec Roy, MB; Alan Breier, MD; Markku Linnoila, MD, PhD; Steven M. Paul, MD

Arch Gen Psychiatry. 1986;43(7):669-676.


Abstract

• The plasma levels of homovanillic acid (HVA), a major circulating dopamine (DA) metabolite, were measured in schizophrenic patients during five weeks each of double-blind placebo-controlled neuroleptic treatment (N =16) and withdrawal (N =11). Both neuroleptic treatment and withdrawal were associated with time-dependent changes in the plasma levels of HVA; treatment was associated with decreases and withdrawal with increases. The levels of plasma HVA measured longitudinally during both conditions were highly correlated with psychosis ratings. Moreover, changes in individual mean weekly levels of plasma HVA were predictive of treatment response, including changes in both positive and negative symptoms of schizophrenia. These data are consistent with the suggestion that the mechanisms of action of antipsychotic drugs involve, in addition to short-term DA receptor blockade, a slowly developing decrease in presynaptic DA activity.



Author Affiliations

From the Section on Clinical Studies, Clinical Neuroscience Branch, National Institute of Mental Health (Drs Pickar, Labarca, Doran, Wolkowitz, Roy, Breier, and Paul), and the National Institute on Alcohol Abuse and Alcoholism, Laboratory of Clinical Studies (Dr Linnoila), Bethesda, Md.


Footnotes

Accepted for publication Sept 6, 1985.

Reprint requests to Section on Clinical Studies, Clinical Neuroscience Branch, National Institute of Mental Health, Bldg 10, Room 4N214, 9000 Rockville Pike, Bethesda, MD 20892-1000 (Dr Pickar).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects
Giltay et al.
J Endocrinol 2005;187:109-116.
ABSTRACT | FULL TEXT  

Schizophrenia
Freedman
NEJM 2003;349:1738-1749.
FULL TEXT  

Autonomic Nervous System Markers of Psychopathology in Childhood-Onset Schizophrenia
Zahn et al.
Arch Gen Psychiatry 1997;54:904-912.
ABSTRACT  

Neuroleptic Withdrawal in Schizophrenic Patients: A Review of the Literature
Gilbert et al.
Arch Gen Psychiatry 1995;52:173-188.
ABSTRACT  

Plasma Homovanillic Acid Levels in First-Episode Schizophrenia: Psychopathology and Treatment Response
Koreen et al.
Arch Gen Psychiatry 1994;51:132-138.
ABSTRACT  

Schizophrenia as a Brain Disease: The Dopamine Receptor Story
Seeman
Arch Neurol 1993;50:1093-1095.
ABSTRACT  

Monoamine Neurotransmitter Interactions in Drug-Free and Neuroleptic-Treated Schizophrenics
John et al.
Arch Gen Psychiatry 1993;50:606-614.
ABSTRACT  

Effects of Metabolic Perturbation on Plasma Homovanillic Acid in Schizophrenia: Relationship to Prefrontal Cortex Volume
Breier et al.
Arch Gen Psychiatry 1993;50:541-550.
ABSTRACT  

Long-term Outcome in Chronic Schizophrenia-Reply
Breier et al.
Arch Gen Psychiatry 1992;49:503-503.
ABSTRACT  

Clinical and Biologic Response to Clozapine in Patients With Schizophrenia: Crossover Comparison With Fluphenazine
Pickar et al.
Arch Gen Psychiatry 1992;49:345-353.
ABSTRACT  

Low Serotonin and Dopamine Metabolite Concentrations in Cerebrospinal Fluid From Bulimic Patients With Frequent Binge Episodes
Jimerson et al.
Arch Gen Psychiatry 1992;49:132-138.
ABSTRACT  

Effects of Neuroleptic Treatment on Symptoms of Schizophrenia and Plasma Homovanillic Acid Concentrations
Davidson et al.
Arch Gen Psychiatry 1991;48:910-913.
ABSTRACT  

National Institute of Mental Health Longitudinal Study of Chronic Schizophrenia: Prognosis and Predictors of Outcome
Breier et al.
Arch Gen Psychiatry 1991;48:239-246.
ABSTRACT  

Changes in Plasma Homovanillic Acid Concentrations in Schizophrenic Patients Following Neuroleptic Discontinuation
Davidson et al.
Arch Gen Psychiatry 1991;48:73-76.
ABSTRACT  

Cerebrospinal Fluid and Plasma Monoamine Metabolites and Their Relation to Psychosis: Implications for Regional Brain Dysfunction in Schizophrenia
Pickar et al.
Arch Gen Psychiatry 1990;47:641-648.
ABSTRACT  

Circadian Variation of Plasma Homovanillic Acid Levels Is Attentuated by Fluphenazine in Patients With Schizophrenia
Doran et al.
Arch Gen Psychiatry 1990;47:558-563.
ABSTRACT  

Increased Numbers of CD5 B Lymphocytes in Schizophrenic Patients
McAllister et al.
Arch Gen Psychiatry 1989;46:890-894.
ABSTRACT  

Effects of Renal Clearance on Plasma Concentrations of Homovanillic Acid: Methodologic Cautions
Potter et al.
Arch Gen Psychiatry 1989;46:558-562.
ABSTRACT  

Plasma 3-Methoxy-4-Hydroxyphenylglycol Changes Associated With Clinical State and Schizophrenic Subtype
Ko et al.
Arch Gen Psychiatry 1988;45:842-846.
ABSTRACT  

Alprazolam Augmentation of the Antipsychotic Effects of Fluphenazine in Schizophrenic Patients: Preliminary Results
Wolkowitz et al.
Arch Gen Psychiatry 1988;45:664-671.
ABSTRACT  

Dopamine Metabolism and Disposition in Schizophrenic Patients: Studies Using Debrisoquin
Maas et al.
Arch Gen Psychiatry 1988;45:553-559.
ABSTRACT  

A Comparison of Plasma Homovanillic Acid Concentrations in Schizophrenic Patients and Normal Controls
Davidson and Davis
Arch Gen Psychiatry 1988;45:561-563.
ABSTRACT  

Plasma Homovanillic Acid as a Predictor of Response to Neuroleptics
Davila et al.
Arch Gen Psychiatry 1988;45:564-567.
ABSTRACT  

Plasma Monoamine Metabolites in Psychotic Disorders
Bowers
Arch Gen Psychiatry 1988;45:595-596.
ABSTRACT  

Increase in Human Urine Homovanillic Acid Concentration After Neuroleptic Treatment Is the Same With or Without Debrisoquin Administration
Contreras et al.
Arch Gen Psychiatry 1987;44:1109-1110.
ABSTRACT  

The Effects of Dexamethasone on Plasma Homovanillic Acid and 3-Methoxy-4-hydroxyphenylglycol: Evidence for Abnormal Corticosteroid-Catecholamine Interactions in Major Depression
Wolkowitz et al.
Arch Gen Psychiatry 1987;44:782-789.
ABSTRACT  

Elevation of Plasma Homovanillic Acid Level Can Be Detected Within Four Hours After Initiation of Haloperidol Treatment
Davila et al.
Arch Gen Psychiatry 1987;44:837-838.
ABSTRACT  

Clinical and Biochemical Effects of Verapamil Administration to Schizophrenic Patients
Pickar et al.
Arch Gen Psychiatry 1987;44:113-118.
ABSTRACT  

Short-term Haloperidol Administration Acutely Elevates Human Plasma Homovanillic Acid Concentration
Davidson et al.
Arch Gen Psychiatry 1987;44:189-190.
ABSTRACT  

Acute Psychosis and Plasma Catecholamine Metabolites
Bowers and Swigar
Arch Gen Psychiatry 1987;44:190-190.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.